drugset / Trial / NCT00401089
Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
Phase 1/2
Completed
60 enrolled
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Imperial College London · collabNorthern Ontario School of Medicine · collabQueen's University · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of the study is to determine whether Panax Ginseng with multiple interactions with key components of brain signaling pathway, can augment the effects of antipsychotics in Schizophrenia. We are primarily interested to examine the actions of Ginseng combined with antipsychotics in improving the ways patients diagnosed with schizophrenia behave in social environment, store, process and retrieve information.
Timeline
- Start
- 2002-12
- Primary completion
- 2006-12
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panax Ginseng | Traditional medicine (herbal / TCM) | 100 mg | Oral |
| Subject | Panax Ginseng | Traditional medicine (herbal / TCM) | 200 mg | Oral |